David N. Fisman
University of Toronto
H-index: 69
North America-Canada
Top articles of David N. Fisman
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex | PNAS | Amy Peng Savana Bosco Alison E Simmons Ashleigh R Tuite David N Fisman | 2024 |
Examining the effects of voluntary avoidance behaviour and policy-mediated behaviour change on the dynamics of SARS-CoV-2: A mathematical model | Infectious Disease Modelling | Gabrielle Brankston David N Fisman Zvonimir Poljak Ashleigh R Tuite Amy L Greer | 2024/4/10 |
Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority | Plos one | David N Fisman Afia Amoako Alison Simmons Ashleigh R Tuite | 2024/4/4 |
Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time … | Microbiology Spectrum | Jean-Paul R Soucy Marcelo Low Kamal R Acharya Moriah Ellen Anette Hulth | 2024/2/27 |
An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel | Animals | Kamal R Acharya Adar Cohen Gabrielle Brankston Jean-Paul R Soucy Anette Hulth | 2024/2/16 |
Modelling Approaches to Borders, Geography, and Infectious Diseases | David Fisman | 2024/2/15 | |
Impact of Community Masking on SARS-CoV-2 Transmission in Ontario after Adjustment for Differential Testing by Age and Sex (preprint) | Amy Peng Savana Bosco Ashleigh Tuite Alison Simmons David Fisman | 2023 | |
Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network study | Vaccine | Karsten Hempel Wade McDonald Nathaniel D Osgood David Fisman Scott A Halperin | 2023/4/6 |
Estimating the test-adjusted incidence of Chlamydia trachomatis infections identified through Public Health Ontario Laboratories in Peel region, Ontario, 2010–2018: a … | Canadian Medical Association Open Access Journal | Lindsay Obress Olaf Berke David N Fisman Shilpa Raju Ashleigh R Tuite | 2023/1/1 |
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: a retrospective cohort study | PLoS One | Alison E Simmons Afia Amoako Alicia A Grima Kiera R Murison Sarah A Buchan | 2023/3/31 |
Real-world evidence in cost-effectiveness analysis of enhanced influenza vaccines in adults≥ 65 years of age: Literature review and expert opinion | Maarten Postma David Fisman Norberto Giglio Sergio Márquez-Peláez Van Hung Nguyen | 2023/6/11 | |
Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2 | Clinical Infectious Diseases | Alicia A Grima Kiera R Murison Alison E Simmons Ashleigh R Tuite David N Fisman | 2023/2/1 |
When the role of uncertainty is… uncertain | Proceedings of the National Academy of Sciences | David N Fisman | 2023/6/6 |
Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis | Clinical Infectious Diseases | Kiera R Murison Alicia A Grima Alison E Simmons Ashleigh R Tuite David N Fisman | 2023/2/1 |
Gravité relative de la pandémie au Canada et dans quatre pays homologues pendant la pandémie de SRAS-CoV-2 | RMTC | Amy Peng Alison Simmons Afia Amoako Ashleigh Tuite David Fisman | 2023/5 |
Impact of Adjustment for Differential Testing by Age and Sex on Apparent Epidemiology of SARS-CoV-2 Infection in Ontario, Canada (preprint) | Savana Bosco Amy Peng Alison E Simmons Ashleigh Tuite David Fisman | 2023 | |
Hepatitis B and C in individuals with a history of antipsychotic medication use: A population-based evaluation | PLoS One | Amnah Awan Sharara Shakik Hailey R Banack David N Fisman Alison E Simmons | 2023/4/14 |
Timing of breakthrough infection risk after vaccination against SARS-CoV-2 | MedRxiv | David N Fisman Nelson Lee Ashleigh R Tuite | 2022/1/5 |
The authors respond to criticisms of their model parameters | CMAJ | David Fisman Ashleigh Tuite Afia Amoako | 2022/6/20 |
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent | BMJ Evidence-Based Medicine | Trisha Greenhalgh David Fisman Danielle J Cane Matthew Oliver Chandini Raina Macintyre | 2022/10/1 |